Efficacy and Safety of Symbravo® in Participants with Migraine Experiencing an Inadequate Response to Oral CGRP Inhibitors
Neurology Minute,
Dr. Bradley Ong shares early insights from the EMERGE trial, presented at the American Headache Society's 67th Annual…